The project is a three-armed study designed to evaluate the efficacy of amodiaquine(AQ),
sulphadoxine-pyrimethamine(SP) and(AQ+SP) in three sites in Cameroon that differ in their
baseline characteristics for malaria. In addition, drug resistance will be determined by
measurement of blood drug levels,and identification of molecular markers of resistance.